On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site ; volume:14 ; pages:930-954
Beilstein journal of organic chemistry ; 14, 930-954
- Classification
-
Chemie
- DOI
-
10.3762/bjoc.14.80
- URN
-
urn:nbn:de:101:1-2018091309344644066569
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates
Antibody–drug conjugates—the magic bullet?
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates
Antibody–drug conjugates—the magic bullet?
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates